Oral glutamine reduces radiation morbidity in breast conservation surgery

Journal of Parenteral and Enteral Nutrition

Volumn 37, Issue 5, 2013, Pages 623-630

  Rubio, Isabel ^a   Suva, Larry J ^b   Todorova, Valentina ^a   Bhattacharyya, Sudeepa ^b   Kaufmann, Yihong ^a   Maners, Anne ^c   Smith, Maureen ^a   Klimberg, V Suzanne ^a  

^a UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^b UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^c CARTI St Vincent   (United States)

Author keywords

nutrition; nutrition support practice; research and diseases

Indexed keywords

GLUTAMINE; GLUTATHIONE; MYOGLOBIN; PLACEBO; PLASMA PROTEIN;

ADULT; ARTICLE; BLOOD; BREAST CANCER; BREAST SURGERY; CANCER RADIOTHERAPY; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; MORBIDITY; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; RADIATION INJURY; SCORING SYSTEM; SURFACE ENHANCED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; TREATMENT OUTCOME;

NUTRITION; NUTRITION SUPPORT PRACTICE; RESEARCH AND DISEASES;

ADMINISTRATION, ORAL; ADULT; AGED; BIOLOGICAL MARKERS; BLOOD PROTEINS; BREAST NEOPLASMS; DOUBLE-BLIND METHOD; FEMALE; FOLLOW-UP STUDIES; GLUTAMINE; GLUTATHIONE; HUMANS; MASTECTOMY, SEGMENTAL; MIDDLE AGED; MYOGLOBIN; RADIATION INJURIES; RADIOTHERAPY; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION;

EID: 84883544985     PISSN: 01486071     EISSN: None     Source Type: Journal    
DOI: 10.1177/0148607112474994     Document Type: Article

References (54)

1. Roth E. Nonnutritive effects of glutamine. J Nutr. 2008 ; 138 (10). 2025S - 2031S
2. Labow BI, Souba WW. Glutamine. World J Surg. 2000 ; 24: 1503-1513
3. Meister A, Anderson MA. Glutathione. Annu Rev Biochem. 1983 ; 52: 711
4. Kosower NS, Kosower EM. The glutathione status of cells. Int Rev Cytol. 1978 ; 54: 109-156
5. Savarese DM, Savy G, Vahdat L, et al. Prevention of chemotherapy and radiation toxicity with glutamine. Cancer Treat Rev. 2003 ; 29: 501-513
6. Welbourne T. Ammonia production and glutamine incorporation into glutathione in the functioning rat kidney. Can J Biochem. 1979 ; 57: 233-237
7. Bongers T, Griffiths RD, McArdle A. Exogenous glutamine: the clinical evidence. Crit Care Med. 2007 ; 35 (9). S545 - S552
8. Klimberg VS. Glutamine, cancer and its therapy. Am J Surg. 1996 ; 172: 418-424
9. Todorova VK, Harms SA, Kaufmann Y, et al. Glutamine supplementation reduces glutathione levels and stimulates apoptosis in DMBA-induced mammary tumors. Breast Cancer Res Treat. 1994 ; 88: 247-256
10. Rouse K, Nwokedi E, Woodliff J, et al. Glutamine enhances sensitivity of chemotherapy through changes in glutathione metabolism. Ann Surg. 1995 ; 221 (4). 420
11. Friezen C, Kiess Y, Debatin KM. A critical role of glutathione in determining apoptosis sensitivity and resistance in leukemia cells. Cell Death Differ. 2004 ; 11: S73 - S85
12. Tormos C, Javier CF, Garcia MJ, et al. Role of glutathione in the induction of apoptosis and c-fos and c-jun mRNAs by oxidative stress in tumor cells. Cancer Lett. 2004 ; 208 (1). 103-113
13. Lopez MJ, Porter KA. Inflammatory breast cancer. Surg Clin North Am. 1996 ; 76 (2). 411-429
14. Hunt KK, Ames FC, Singletary SE, Buzdar AU, Hortobagyi GN. Locally advanced noninflammatory breast cancer. Surg Clin North Am. 1996 ; 76 (2). 393-409
15. Cuzick J, Stewart HJ, Peto R, et al. Overview of randomized trials of postoperative adjuvant radiotherapy in breast cancer. Cancer Res. 1988 ; 111: 108-129
16. Donegan WL, Spratt JS Cancer of the Breast. 4 th ed.Philadelphia, PA: Saunders; 1995. Philadelphia, PA: Saunders ; 1995 :
17. Nguyen DT, Keast D. Energy metabolism and the skin. J Biochem. 1991 ; 23 (11). 1175-1183
18. Mansfield CA, Krishanm L, Komarnicky LT. A review of the role of radiation therapy in the treatment of patients with breast cancer. Semin Oncol. 1991 ; 18 (6). 525-535
19. Morrow M, Strom EA, Bassett LW, et al. Standard for breast conservation therapy in the management of invasive breast carcinoma. CA Cancer J Clin. 2002 ; 52 (5). 277-300
20. Mendelson EB. Evaluation of postoperative breast. Radiol Clin North Am. 1992 ; 30: 107-138
21. Petricoin EF, Ornstein DK, Liotta LA. Clinical proteomics: applications for prostate cancer biomarker discovery and detection. Urol Oncol. 2004 ; 22: 322-328
22. Ziegler TR, Benfell K, Smith RJ, et al. Safety and metabolic effects of L-glutamine administration in humans. JPEN J Parenter Enteral Nutr. 1990 ; 14 (4). 137S - 146S
23. Nahorski SR. Fluorometric measurement of glutamine and asparagine using enzymic methods. Anal Biochem. 1971 ; 42: 136-142
24. Tietze F. Enzymatic method for quantitative determination of nanogram amounts of total and oxidized glutathione: applications to mammalian blood and other tissues. Ann Biochem. 1969 ; 27: 502-522
25. Anderson ME Glutathione. Dolphin D, ed. New York: John Wiley ; 1983 :
26. Kohli M, Siegel E, Bhattacharya S, et al. Surface-enhanced laser desorption/ionization time-of-flight mass spectrometry (SELDI-TOF MS) for determining prognosis in advanced stage hormone relapsing prostate cancer. Cancer Biomark. 2006 ; 2 (6). 249-258
27. Bhattacharyya S, Siegel ER, Achenbach SJ, et al. Serum biomarker profile associated with high bone turnover and BMD in postmenopausal women. J Bone Miner Res. 2008 ; 23 (7). 1106-1117
28. Klimberg VS, Souba WW, Dolson DJ, et al. Prophylactic glutamine protects the intestinal mucosa from radiation injury. Cancer. 1990 ; 66 (1). 62-68
29. Suckau D, Cornett DS. Protein sequencing by ISD and PSD MALDI-TOF MS. Analusis. 1998 ; 26: 18-21
30. Caputo E, Moharram R, Martin BM. Methods for on-chip protein analysis. Anal Biochem. 2003 ; 321 (1). 116-124
31. Brewis IA, Brennan P. Proteomics technologies for the global identification and quantification of proteins. Adv Protein Chem Struct Biol. 2010 ; 80: 1-44
32. Biaglow JE, Varnes ME, Epp ER, et al. Role of glutathione and other thiols in the cellular response to radiation and drugs. Drug Metab Rev. 1989 ; 20 (1). 1-12
33. Zhao Y, Seefeldt T, Chen W, et al. Increase in thiol oxidative stress via glutathione reductase inhibition as a novel approach to enhance cancer sensitivity to X-ray irradiation. Free Radic Biol Med. 2009 ; 47 (2). 176-183
34. Souba WW, Klimberg VS, Hautamaki RD, et al. Oral glutamine reduces bacterial translocation following abdominal radiation. J Surg Res. 1990 ; 48: 1-5
35. Zetterberg A, Engstrom W. Glutamine and the regulation of DNA replication and cell multiplication in fibroblasts. J Cell Physiol. 1978 ; 95: 41-48
36. Dall'Asta V, Rossi P, Bussolati A, et al. The transport of L-glutamine into cultured human fibroblasts. Biochim Biophys Acta. 1990 ; 1052: 106-112
37. Zielke HR, Ozand PT, Tildon JT, et al. Reciprocal regulation of glucose and glutamine utilization by cultured human diploid fibroblasts. J Cell Physiol. 1978 ; 95: 41-48
38. Archambeau JO, Pezner R, Wasserman T. Pathophysiology of irradiated skin and breast. Int J Radiat Oncol Biol Phys. 1995 ; 31 (5). 1171-1185
39. Nguyen DT, Keast D. Energy metabolism and the skin. J Biochem. 1991 ; 23 (11). 1175-1183
40. White J, Joiner MC. Toxicity from radiation in breast cancer. Cancer Treat Res. 2006 ; 128: 65-109
41. Harris JR, Recht A Breast Disease. 2 nd ed.Philadelphia, PA: JB Lippincott; 1991:395. Harris JR Hellina S Henderson IC, ed. Philadelphia, PA: JB Lippincott ; 395.
42. Brown WD, Akoyunoglou JA. Gamma-irradiation of purified myoglobin, I: effect on physicochemical properties. Arch Biochem Biophys. 1964 ; 107: 239
43. Clarke R, Richards JF. Effect of gamma-irradiation on beef myoglobin. J Agric Food Chem. 1971 ; 19 (1). 170-174
44. Iyer S, Olivares J. Trypsin digestion of proteins on intact immobilized pH gradient strips for surface matrix-assisted laser desorption/ionization time-of-flight mass spectrometric analysis. Rapid Commun Mass Spectrom. 2003 ; 17 (20). 2323-2326
45. Wittenberg JB, Wittenberg BA. Myoglobin function reassessed. J Exp Biol. 2003 ; 206: 2011-2020
46. Garry DJ, Mammen PP. Molecular insights into the functional role of myoglobin. Adv Exp Med Biol. 2007 ; 618: 181-193
47. Burmester T, Gerlach F, Hankeln T. Regulation and role of neuroglobin and cytoglobin under hypoxia. Adv Exp Med Biol. 2007 ; 618: 169-180
48. Galluzzo M, Pennacchietti S, Rosano S, et al. Prevention of hypoxia by myoglobin expression in human tumor cells promotes differentiation and inhibits metastasis. J Clin Invest. 2009 ; 119: 865-875
49. Dang CV, Kim JW, Gao P, et al. The interplay between MYC and HIF in cancer. Nat Rev Cancer. 2008 ; 8: 51-56
50. Flögel U, Dang CV. Myoglobin tames tumor growth and spread. J Clin Invest. 2009 ; 119 (4). 766-768
51. Dewhirst MW, Cao Y, Moeller B. Cycling hypoxia and free radicals regulate angiogenesis and radiotherapy response. Nat Rev Cancer. 2008 ; 8: 425-437
52. Flögel U, Laussmann T, Gödecke A, et al. Lack of myoglobin causes a switch in cardiac substrate selection. Circ Res. 2005 ; 96 (8). e68 - e75
53. Gloster J, Harris P. Fatty acid binding to cytoplasmic proteins of myocardium and red and white skeletal muscle in the rat: a possible new role for myoglobin. Biochem Biophys Res Commun. 1977 ; 74: 506-513
54. Sriram R, Kreutzer U, Shih L, et al. Interaction of fatty acid with myoglobin. FEBS Lett. 2008 ; 582 (25-26). 3643-3649